Source: MarketScreener

Cidara: Cidara Therapeutics : Official notification to shareholders of matters to be brought to a vote ("Proxy")

(marketscreener.com) above and 52,592 shares held by Mr. Daruwala and 122,390 shares of common stock that Mr. Daruwala has the right to acquire from us within 60 days of April 27, 2020 , 61,891 shares held by Mr. Levine and 74,792 shares of common stock that Mr. Levine has the right to acquire from us within 60 days of April 27, 2020 , and 6,965 shares held by Ms....https://www.marketscreener.com/CIDARA-THERAPEUTICS-INC-21685642/news/Cidara-Therapeutics-Official-notification-to-shareholders-of-matters-to-be-brought-to-a-vote-Pro-30666889/?utm_medium=RSS&utm_content=20200525

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Jeffrey Stein's photo - President & CEO of Cidara

President & CEO

Jeffrey Stein

CEO Approval Rating

90/100

Cidara develops and commercializes novel anti-infectives and immunotherapies for the treatment of fungal infections. Read more